Semaglutide Lawsuits: Link Between Diabetes Drug and Rare Vision Damage Under Scrutiny
Dozens of patients are suing Novo Nordisk over claims that semaglutide caused rare optic nerve damage. The pharmaceutical company denies the allegations, citing insufficient evidence.




























